22320 Federal Register / Vol. 77, No. 72 / Friday, April 13, 2012 / Notices 

EARLY TERMINATIONS GRANTED—Continued 

MARCH 1, 2012 THRU MARCH 31, 2012 

20120627 ...... G Wendel SA; Loma International Corporation; Wendel SA. 

20120628 ...... G Mercer International Inc.; Fibrek Inc.; Mercer International Inc. 

20120629 ...... G Precision Castparts Corp.; RathGibson Holding Co. LLC; Precision Castparts Corp. 

20120630 ...... G Audax Private Equity Fund III, L.P.; Brazos Equity Fund III, L.P.; Audax Private Equity Fund III, L.P. 

20120632 ...... G Ocwen Financial Corporation; Morgan Stanley; Ocwen Financial Corporation. 

20120636 ...... G Wynnchurch Capital Partners III, L.P.; Mueller Water Products, Inc.; Wynnchurch Capital Partners III, L.P. 

20120638 ...... G Fertitta Investment LLC; Station Holdco LLC; Fertitta Investment LLC. 

03/26/2012 

20120569 ...... G Glory Limited; Carlyle Europe Partners III, L.P.; Glory Limited. 

20120631 ...... G Nuance Communications, Inc.; Transcend Services, Inc.; Nuance Communications, Inc. 

03/27/2012 

20120586 ...... G Franz Haniel & Cie. GmbH; G. Thomas Patton, III; Christopher N. Patton; Franz Haniel & Cie. GmbH. 

20120649 ...... G Howard Midstream Energy Partners, LLC; EnCap Energy Infrastructure Fund, L.P.; Howard Midstream Energy Partners, 

LLC. 

03/28/2012 

20120620 ...... G Golden Gate Capital Opportunity Fund, L.P.; Infor Enterprise Applications Ltd.; Golden Gate Capital Opportunity Fund, 

L.P. 

03/29/2012 

20120648 ...... G Mr. Mark Zuckerberg; Mr. Mark Zuckerberg; Mr. Mark Zuckerberg. 

03/30/2012 

20111374 ...... G Humana Inc.; Arcadian Management Services, Inc.; Humana Inc. 

20120633 ...... G OHI Parent, Inc.; Osmose Holdings, Inc.; OHI Parent, Inc. 

20120637 ...... G Wellspring Capital Partners V, L.P.; Industrial Growth Partners III, L.P.; L.P. 

20120644 ...... G MDCP VI–A Global Investments, LP; Pinafore Investment Cooperatief U.A.; MDCP VI–A Global Investments, LP. 

20120653 ...... G Riverside Capital Appreciation Fund V LP; The Riverstone Group, LLC; Fund V LP. 

20120655 ...... G Sumitomo Corporation; Midas, Inc.; Sumitomo Corporation. 

20120657 ...... G The Procter & Gamble Company; New Chapter, Inc.; The Procter & Gamble Company. 

For Further Information Contact: 

Renee Chapman, Contact 

Representative, or 

Theresa Kingsberry, 

Legal Assistant, Federal Trade 

Commission, Premerger Notification 

Office, Bureau Of Competition, Room 

H–303, Washington, DC 20580, (202) 

326–3100. 

By Direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2012–8734 Filed 4–12–12; 8:45 am] 

BILLING CODE 6750–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Peter J. Francis, M.D., Ph.D., Oregon 

Health Sciences University: Based on 

the report of an investigation conducted 

by Oregon Health Sciences University 

(OHSU) and additional analysis 

conducted by ORI in its oversight 

review, ORI found that Dr. Peter J. 

Francis, Associate Professor, Casey Eye 

Institute, OHSU, engaged in research 

misconduct in research reported in two 

grant applications, R01 EY021214–01 

and resubmitted as R01 EY021214– 

01A1, that he submitted to the National 

Eye Institute (NEI), National Institutes of 

Health (NIH). 

Specifically, ORI finds that the 

Respondent fabricated results of a pilot 

experiment in which he claimed to have 

injected retinal pigment epithelial (RPE) 

cells obtained from Rhesus monkey 

embryonic stem cells (ECS) into a strain 

of rats (RCS) that develops retinal 

degeneration. 

Respondent claimed that after the 

injection of ECS-derived RPE cells 21 

days postnatal, the rats were tested at 

day 60 postnatal for optomotor acuity, 

and that the retinal histology of eyes 

receiving ECS-derived RPE cells, 

compared to mock-injected controls, 

showed enhanced photoreceptor 

preservation and no adverse effects. 

Respondent admitted that this 

experiment had not been conducted 

either by the time the original grant 

application had been submitted or by 

the time the later R01 EY021214–01A1 

application was submitted. 

Dr. Francis has entered into a 

Voluntary Settlement Agreement 

(Agreement) and has voluntarily agreed 

for a period of two (2) years, beginning 

on March 29, 2012: 

(1) To have his research supervised; 

Respondent agrees to ensure that prior 

to the submission of an application for 

U.S. Public Health Service (PHS) 

support for a research project on which 

the Respondent’s participation is 

proposed and prior to Respondent’s 

participation in any capacity on PHSsupported research, the institution 

employing him must submit a plan for 

supervision of Respondent’s duties to 

ORI for approval; the plan for 

supervision must be designed to ensure 

the scientific integrity of Respondent’s 

research contribution; Respondent 

agrees that he shall not participate in 

any PHS-supported research after sixty 


pmangrum on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 72 / Friday, April 13, 2012 / Notices 22321 

(60) days from the effective date of this 

Agreement until such a supervision 

plan is submitted to and approved by 

ORI; Respondent agrees to maintain 

responsibility for compliance with the 

agreed upon supervision plan; 

(2) that this supervisory plan 

provided by any institution employing 

him shall provide assurance that each 

application for PHS funds, or report, 

manuscript, or abstract involving PHS 

supported research in which 

Respondent was involved was based on 

actual experiments or was otherwise 

legitimately derived, that the data, 

procedures, and methodology were 

accurately reported in the application, 

report, manuscript, or abstract, and that 

the text in such submissions was his 

own or properly cited the source of 

copied language and ideas; and 

(3) to exclude himself from serving in 

any advisory capacity to PHS including, 

but not limited to, service on any PHS 

advisory committee, board, and/or peer 

review committee, or as a consultant. 

FOR FURTHER INFORMATION CONTACT: 

Director, Division of Investigative 

Oversight, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852, (240) 453–8800. 

John Dahlberg, 

Director, Division of Investigative Oversight, 

Office of Research Integrity. 

[FR Doc. 2012–8903 Filed 4–12–12; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the President’s Council on 

Fitness, Sports, and Nutrition 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health, Office of the President’s Council 

on Fitness, Sports, and Nutrition. 

ACTION: Notice of meeting. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services (DHHS) is hereby giving notice 

that the President’s Council on Fitness, 

Sports, and Nutrition (PCFSN) will hold 

a meeting. The meeting will be open to 

the public. 

DATES: The meeting will be held on May 

1, 2012, from 10 a.m. to 3 p.m. 

ADDRESSES: Department of Health and 

Human Services, 200 Independence 

Ave. SW., Room 800, Washington, DC 

20201. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Shellie Pfohl, Executive Director, 

President’s Council on Fitness, Sports, 

and Nutrition, Tower Building, 1101 

Wootton Parkway, Suite 560, Rockville, 

MD 20852, (240) 276–9866. Information 

about PCFSN, including details about 

the upcoming meeting, can be obtained 

at www.fitness.gov and/or by calling 

(240) 276–9567. 

SUPPLEMENTARY INFORMATION: On June 

23, 2010, the President established 

Executive Order 13545 to amend 

Executive Order 13265, dated June 6, 

2002. Under Executive Order 13545, 

direction is given for the scope of the 

President’s Council on Physical Fitness 

and Sports to be expanded to recognize 

that good nutrition goes hand in hand 

with fitness and sports participation. 

Executive Order 13545 gives authority 

for the title of the Council to be revised 

to include nutrition. 

The primary functions of the PCFSN 

include (1) Advising the President, 

through the Secretary, concerning 

progress made in carrying out the 

provisions of Executive Order 13545 

and shall recommend to the President, 

through the Secretary, actions to 

accelerate progress; (2) advising the 

Secretary on ways to promote regular 

physical activity, fitness, sports 

participation, and good nutrition. 

Recommendations may address, but are 

not necessarily limited to, public 

awareness campaigns; Federal, State, 

and local physical activity; fitness, 

sports participation, and nutrition 

initiatives; and partnership 

opportunities between public- and 

private-sector health promotion entities; 

(3) functioning as a liaison to relevant 

State, local, and private entities in order 

to advise the Secretary regarding 

opportunities to extend and improve 

physical activity, fitness, sports, and 

nutrition programs and services at the 

local, State, and national levels; and (4) 

monitoring the need to enhance 

programs and educational and 

promotional materials sponsored, 

overseen, or disseminated by the 

Council, and shall advise the Secretary, 

as necessary, concerning such need. In 

performing its functions, the Council 

shall take into account the Federal 

Dietary Guidelines for Americans and 

the Physical Activity Guidelines for 

Americans. 

The PCFSN will hold, at a minimum, 

one meeting in a calendar year. The 

meeting will be held to (1) assess 

ongoing Council activities and (2) 

discuss and plan future projects and 

programs. The agenda for the planned 

meeting is being developed and will be 

posted at www.fitness.gov when it has 

been finalized. 

The meeting that is scheduled to be 

held May 1, 2012 is open to the public. 

Every effort will be made to provide 

reasonable accommodations for persons 

with disabilities and/or special needs 

who wish to attend the meeting. Persons 

with disabilities and/or special needs 

should call (240) 276–9567 no later than 

close of business on April 23, 2012, to 

request accommodations. Members of 

the public who wish to attend the 

meeting are asked to pre-register by 

calling (240) 276–9567. Registration for 

public attendance must be completed 

before close of business on April 23, 

2012. 

Dated: March 9, 2012. 

Shellie Y. Pfohl, 

Executive Director, President’s Council on 

Fitness, Sports, and Nutrition. 

[FR Doc. 2012–8900 Filed 4–12–12; 8:45 am] 

BILLING CODE 4150–35–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Toxicology Program (NTP) 

Interagency Center for the Evaluation 

of Alternative Toxicological Methods: 

Call for Nominations of High 

Throughput Screening (HTS) Assays 

for the Tox21 Initiative 

AGENCY: Division of the National 

Toxicology Program (DNTP), National 

Institute of Environmental Health 

Sciences (NIEHS), National Institutes of 

Health (NIH). 

ACTION: Call for nominations. 

SUMMARY: The multiagency Tox21 

Initiative aims to improve hazard 

assessment of compounds potentially 

harmful to humans and the 

environment. This will be accomplished 

through the use of integrated high 

throughput screens that provide 

information on the ability of a substance 

to perturb biological pathways related to 

toxicity. On behalf of the Tox21 

Consortium and its Assays and 

Pathways Working Group, the NTP 

Interagency Center for the Evaluation of 

Alternative Toxicological Methods 

(NICEATM) is accepting nominations 

for HTS biochemical- or cell-based 

assays. Assays selected for further 

evaluation and found to be compatible 

with the HTS program will support 

Tox21 by providing data on endpoints 

that serve as markers for initiating or 

downstream events in toxicity 

pathways. 

DATES: The nomination of HTS assays to 

Tox21 is an ongoing process and will 

continue to remain open. Periodic 

updates to this notice may be posted to 

reflect new focus areas of the Tox21 

HTS program. 


pmangrum on DSK3VPTVN1PROD with NOTICES